Industry Trend Analysis - Core Growth Drivers Deliver Impressive Sales Returns For Bayer - 22 MAY 2017
Corporate Financing week May 2017 / Germany / Industry
Bayer's better-than-expected Q117 financial results bode well for the company's outlook for 2017. Growth was largely driven by consistently strong business developments within the pharmaceuticals...
Industry Trend Analysis - Increased M&A Likely As Chinese Competition Rises - 01 MAY 2017
Corporate Financing week April 2017 / Global / Industry
As Chinese infrastructure firms expand globally, there is the potential for increased M&A activity as established, incumbent firms aim to improve competitiveness and Chinese companies...
Industry Trend Analysis - Acquisition Bids Highlight Strength Of Stada's Business - 13 MAR 2017
Corporate Financing week March 2017 / Germany / Industry
Potential interest in acquiring Stada Arzneimittel has been building for almost a year, and has now come into the open with these three initial bids. Interest from other firms is certainly a possib...
Industry Trend Analysis - Azaya Acquisition Will Benefit Cytori's Cell Therapy Pipeline - 06 MAR 2017
Corporate Financing week March 2017 / United States / Industry
Cytori's acquisition of Azaya Therapeutics will provide the company with a nanoparticle platform that it can apply to its current pipeline to aid in delivery. The two near-to-market oncology compou...
Company Trend Analysis - Komatsu Acquisition Of Joy Global: Initial Thoughts - 01 AUG 2016
Corporate Financing week July 2016 / Vietnam / Industry
The acquisition of US mining machinery company Joy Global by Japanese machinery major Komatsu illustrates a number of key trends in the machinery industry as well as highlights several of our key...
Industry Trend Analysis - Medivation Trying To Ignite Bidding War - 25 JULY 2016
Corporate Financing week July 2016 / United States / Industry
A bidding war will likely ensue after Medivation has essentially put itself up for sale. Sanofi could eventually conquer Medivation, but a challenge from Pfizer is probable. Xtandi appears to be...
Industry Trend Analysis - Lupin On Course To Cement Place In US Market - 14 MAR 2016
Corporate Financing week March 2016 / India / Industry
US FTC consent for Lupin's proposed acquisition of Gavis Pharmaceuticals brings the acquisition a step closer to completion, and with only two products to be divested, the acquisition will be a...
Industry Trend Analysis - Hikma On Track To Boost US Generic Injectables Presence - 07 MAR 2016
Corporate Financing week March 2016 / United States / Industry
Despite the divestitures required by the FTC, Hikma's ongoing acquisition of what was essentially Boehringer Ingelheim's entire generics business will serve to substantially increase Hikma's positi...
Industry Trend Analysis - Pfizer-Allergan Tax Inversion To Close Despite Opposition - 30 NOV 2015
Corporate Financing week November 2015 / United States / Industry
Pfizer's controversial 'tax inversion' of Allergan is likely to close despite bipartisan annoyance at the deal, which will deprive the US Treasury of billions of dollars in taxes over the next few years. It is too late for Congress to pass legislation to prevent such deals before the 2016 presidential election. While the government has the authority to implement retroactive changes to the rules...
READ FULL ARTICLE
Corporate Financing Analysis - Leighton's Importance Highlighted By ACS' Assertions - 24 MAR 2014
Corporate Financing week March 2014 / Australia / Finance
We believe Hochtief's push for greater board representation and ownership of Leighton highlight the growing importance of Leighton Holdings on Hochtief's parent company, ACS - an unsurprising...